ORIONINFU

Orion Infusion Ltd. · Pharmaceuticals and Chemicals · Cat A

0/100

High risk

৳290.9

Score breakdown

Technical read

RSI (14)34.5

MACDbearish

Bollingerbelow lower band

Price cycle (Wyckoff)ACCUM

Health trenddeteriorating

Flow pressureneutral

Valuation

Fair value ()

Upside—

Dividend yield+0.70%

Fundamental verdictAT-RISK

Confidence—

Levels

Resistance

৳305.5

৳319.7

৳330.6

৳340.9

Support

৳290

৳279.1

৳269

৳255.7

Historical bounce zones

Dec 11, 2024: ৳265.4→৳437.9 +65%

Jan 28, 2025: ৳357.1→৳426 +19%

Jun 22, 2025: ৳303.3→৳549 +81%

Aug 26, 2025: ৳492→৳587.5 +19%

Oct 12, 2025: ৳450→৳524 +16%

Nov 6, 2025: ৳349→৳402 +15%

Nov 16, 2025: ৳318→৳398.8 +25%

Dec 29, 2025: ৳336.7→৳389 +16%

Historical outlook

Based on how similar setups behaved historically — not a prediction of what will happen.

10-day 48% vs 40% market avg Typical move: -4.4% / 0.1% / 5.1%

30-day 50% vs 42% market avg Typical move: -7.5% / -0.1% / 8.4%

Signals: RSI<30 oversold|Below lower Bollinger|Evening Star

Reference levels

Descriptive reference points from the analysis — not instructions to buy or sell.

Entry readAVOID (dormant/dirty)

Reference stopn/a

Reference target—

Timing notestay out

extreme artificial activity (score 863); speculative profile — not core-quality. Phase: DORMANT (-23% >200-MA, flow neut) -> watch. History of artificial price activity (regulator-cited). ⚠ SOLVENCY DISTRESS (Altman Z 1.08, STABLE) — bankruptcy risk. high-risk. [fundamentals AT-RISK (dividend cut risk), payout 116.0%, yield 0.7%]

Market activity

Block activity

Block trade ৳0.6M (1 trade), 0.8× normal public volume, institutional ownership -0.2pp.